Aspen Aerogels Toekomstige groei
Future criteriumcontroles 2/6
De verwachting is dat Aspen Aerogels de winst en omzet met respectievelijk 103.4% en 25.6% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 104.1% per jaar.
Belangrijke informatie
103.4%
Groei van de winst
104.06%
Groei van de winst per aandeel
| Chemicals winstgroei | 21.8% |
| Inkomstengroei | 25.6% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 07 Aug 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • Sep 05
ASPN: Q2 Beat And EBITDA Turn Will Test Execution And Profitability
Analysts recently lifted their price targets on Aspen Aerogels to a range between $5 and $9, reflecting updated views on fair value after the company reported a solid Q2 beat, guided to a return to positive adjusted EBITDA, and noted what they describe as improved visibility across both operating segments. Analyst Commentary Recent research on Aspen Aerogels highlights a mixed tone.
Narratiefupdate • Aug 22
ASPN: Positive EBITDA Guidance And Q2 Execution Will Support Future Upside
Analysts have lifted their fair value estimate for Aspen Aerogels from $8.00 to $10.00 after recent price target increases that they link to a solid Q2 performance, a return to positive adjusted EBITDA guidance, and what they describe as better visibility across the company’s segments. Analyst Commentary Recent commentary around Aspen Aerogels has centered on fresh price target increases that reflect how analysts are interpreting the latest Q2 report.Seeking Alpha • Aug 10
Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot
Summary Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science. But…. Aspen Aerogels is an example of why we should look beyond chicness. It has a simple and recently depressed business selling high performance protective barriers. They’re vital for EV batteries, to prevent heat from spreading and leading to explosions. They’re also useful for LNG transmission. EVs demand is starting to recover. That’s good. Better still…. Materials keep evolving and new uses surface. ASPN is preparing to adapt its wares to data centers, grid overhaul, and lots more. That makes the stock a speculative “Buy.”. Read the full article on Seeking Alpha
Narratiefupdate • Aug 08
ASPN: Improved Segment Visibility And Restart Progress May Support Future Upside
Analysts have lifted the fair value estimate for Aspen Aerogels from $6.35 to $7.55, citing higher modeled revenue growth, a slightly stronger long term profit margin profile, and recent Street research pointing to better visibility across both operating segments after the latest quarterly updates. Analyst Commentary Recent Street research on Aspen Aerogels points to higher conviction around the company’s outlook following the latest quarterly update.Narratiefupdate • Jul 14
ASPN: Explosion Disruption And Weaker Margins Will Pressure Shares
Aspen Aerogels’ analyst price target has been raised by $1 as analysts point to updated assumptions around fair value, revenue growth, profit margins, discount rate and future P/E to support the change. What's in the News for Aspen Aerogels Aspen Aerogels reported an explosion at its East Providence, Rhode Island manufacturing facility on April 8, 2026.Narratiefupdate • Jun 30
ASPN: Cost Controls And Facility Restart Will Support Future Upside
Analysts have lifted their fair value estimate for Aspen Aerogels to $8.00 from $6.00, citing updated assumptions around revenue growth, profit margins, discount rates and future P/E expectations as reflected in recent Street research, including the latest $1 price target increase from Barclays. What's in the News Aspen Aerogels reported that an explosion occurred at its East Providence, Rhode Island manufacturing facility on April 8, 2026, damaging a portion of the production space and leading to a temporary halt of operations, with an investigation into the cause ongoing.Narratiefupdate • Jun 16
ASPN: Fair Outlook As Restart Progress And Refinements Shape Future Stock Performance
Analysts have lifted their Aspen Aerogels price target by $1, citing updated assumptions around discount rates, profit margins and future P/E that refine rather than overhaul their prior valuation work. What’s in the News for Aspen Aerogels Aspen Aerogels began a staged restart of manufacturing operations at its East Providence, Rhode Island facility after completing mechanical, operational, and safety reviews in coordination with local, state, and federal agencies.Narratiefupdate • Jun 02
ASPN: Fair Outlook Balances Facility Setback With Long-Term Opportunity
Analysts have adjusted their outlook on Aspen Aerogels with a modestly lower price target, citing updated views on growth, profitability, and valuation following recent Street research moves that included a $1 reduction and a separate $1 increase in targets at $3 and $4. Analyst Commentary Recent research on Aspen Aerogels reflects a mix of caution and selective optimism, centered on updated views of growth, execution, and valuation following the latest price target changes.Narratiefupdate • Apr 30
ASPN: GM Demand Reset And Facility Disruption Will Pressure Shares
Analysts have cut Aspen Aerogels' price targets into a lower $3 to $6 range, citing Q4 and Q1 misses, GM related EV demand weakness, and a tough near term outlook, partially balanced by cost actions, a growing net cash position, and what they see as longer term platform value. Analyst Commentary Recent Street research highlights that several bearish analysts have reset expectations lower for Aspen Aerogels, trimming price targets into a $3 to $6 range after the Q4 earnings miss and a soft Q1 outlook.Narratiefupdate • Apr 15
ASPN: GM Demand Reset And Tough Outlook Will Pressure Shares
Analysts have cut their average price targets on Aspen Aerogels to a range of about $3 to $6. This reflects weaker near term expectations tied to GM related EV softness, offset by company efforts to protect cash, reduce costs, and focus on longer term platform value.Narratiefupdate • Apr 01
ASPN: Cost Discipline And GM Settlement Cash Will Support Future Upside
Analysts have reduced their average price targets on Aspen Aerogels to a range of about $3 to $6, citing Q4 earnings and guidance shortfalls, ongoing softness tied to GM and the broader EV reset, as well as a sharper company focus on cash preservation and cost controls. Analyst Commentary Across recent research notes, analysts broadly cut price targets on Aspen Aerogels following Q4 results and softer guidance, but the tone is mixed rather than uniformly negative.Narratiefupdate • Mar 18
ASPN: Cost Actions And Cash Support Will Drive Long-Term Upside Potential
Analysts have reduced the fair value estimate for Aspen Aerogels from $10 to $6, reflecting lower price targets across the Street as they weigh weaker GM related EV demand against the company's cost actions, cash support from the GM settlement, and longer term platform potential. Analyst Commentary Street research has shifted sharply lower on headline price targets, but the tone is not uniformly negative.Narratiefupdate • Mar 04
ASPN: Tough Year And GM Demand Reset Will Pressure Shares
Narrative Update: Aspen Aerogels The analyst price target for Aspen Aerogels has moved from $6.00 to $3.00 as analysts factor in a tough year following a Q4 earnings miss and softer guidance, partly offset by cost actions and a stronger net cash position tied to the GM settlement. Analyst Commentary Bearish analysts have reset expectations for Aspen Aerogels, cutting price targets across the board after the Q4 earnings miss and softer near term guidance.Narratiefupdate • Feb 18
ASPN: Updated Profitability Assumptions Will Still Support Long-Term Upside Potential
Analysts have lifted their price target for Aspen Aerogels to $10.00, citing updated inputs around revenue growth, profit margins, and future P/E assumptions as the key drivers of this change. Valuation Changes Fair Value: revised slightly from $9.98 to $10.00 per share, aligning with the updated price target.Narratiefupdate • Feb 04
ASPN: Higher 2025 Loss Guidance Will Still Support Long-Term Opportunity
Analysts have adjusted their price target on Aspen Aerogels, highlighting a slightly higher discount rate and future P/E assumptions, along with modest tweaks to revenue growth and profit margin expectations, as they reassess the risk and earnings profile embedded in their valuation models. What's in the News Aspen Aerogels revised full year 2025 revenue guidance to a range of $270 million to $280 million, compared with prior guidance of $297 million to $317 million (company guidance).Analyse-artikel • Jan 23
Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge Not Quite Adding Up
Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 32% in the...Narratiefupdate • Jan 20
ASPN: Lower 2025 Guidance Will Still Support Long-Term Upside Potential
Analysts have raised their price targets on Aspen Aerogels, citing updated assumptions for the discount rate, revenue growth, profit margin, and future P/E that together suggest a modest improvement in their overall outlook for the shares. What's in the News Aspen Aerogels revised its full-year 2025 revenue guidance to a range of US$270 million to US$280 million, compared with prior guidance of US$297 million to US$317 million (company guidance).Narratiefupdate • Jan 06
ASPN: Lower 2025 Outlook Will Still Support Attractive Long-Term Upside Potential
Analysts have lifted their price target on Aspen Aerogels to reflect updated assumptions around revenue growth, profit margins, discount rate and future P/E. The new target implies a valuation aligned with these revised inputs compared with the prior figure.Narratiefupdate • Dec 19
ASPN: Reduced Guidance And Higher Discount Rate Will Present Long-Term Upside Opportunity
Aspen Aerogels' consensus analyst price target has been reduced by approximately $4.02 per share, as analysts temper their assumptions for revenue growth and profit margins, while also applying a slightly higher discount rate and multiple to future earnings. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from prior expectations of $297 million to $317 million (Key Developments).Narratiefupdate • Dec 05
ASPN: Improving Risk Profile Will Support Long-Term Opportunity Despite Wider Losses
Analysts have raised their price target on Aspen Aerogels by a modest amount, now embedding slightly lower discount rates and marginally softer future valuation multiples, as they emphasize the company’s improving risk profile and steady long term growth outlook. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from the prior outlook of $297 million to $317 million (company guidance).Analyse-artikel • Dec 04
Aspen Aerogels (NYSE:ASPN) Might Have The Makings Of A Multi-Bagger
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Narratiefupdate • Nov 21
ASPN: Lower Profit Margins Will Drive Opportunity As Net Losses Peak
Analysts have lowered their price target for Aspen Aerogels from $8.75 to $6.83 per share. They cite revised expectations for slower revenue growth and profit margins.Narratiefupdate • Nov 07
ASPN: Reduced EV Tax Credits Will Challenge Thermal Segment Performance Ahead
Analysts have lowered their price target for Aspen Aerogels from $9.58 to $8.75. They cited reduced electric vehicle production forecasts and increased macroeconomic pressures on the company’s key Thermal Barrier business segment.Analyse-artikel • Oct 11
Optimistic Investors Push Aspen Aerogels, Inc. (NYSE:ASPN) Shares Up 27% But Growth Is Lacking
Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a really impressive month, gaining 27% after a shaky period...Analyse-artikel • Aug 09
Aspen Aerogels, Inc. (NYSE:ASPN) Analysts Are Pretty Bullish On The Stock After Recent Results
NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...Narratiefupdate • Aug 08
Cost Optimization And Industrial Demand Will Shape Future Markets
The consensus price target for Aspen Aerogels has increased, reflecting a higher valuation multiple (future P/E rising from 14.46x to 20.08x) despite a notable decline in net profit margin (from 14.47% to 11.75%), resulting in a new fair value estimate of $9.75. What's in the News Ricardo Rodriguez will step down as CFO at the end of Q3 and be succeeded by Grant Thoele, who currently serves as Chief of Staff and VP of Corporate Strategy and Finance.Analyse-artikel • Aug 06
Aspen Aerogels, Inc.'s (NYSE:ASPN) Shares Climb 28% But Its Business Is Yet to Catch Up
NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...Analyse-artikel • Jul 09
Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyse-artikel • Jun 11
Aspen Aerogels, Inc.'s (NYSE:ASPN) 29% Share Price Surge Not Quite Adding Up
Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 29% in the...Analyse-artikel • Apr 17
Not Many Are Piling Into Aspen Aerogels, Inc. (NYSE:ASPN) Stock Yet As It Plummets 30%
To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 30% in the...Analyse-artikel • Apr 01
Aspen Aerogels (NYSE:ASPN) Has A Pretty Healthy Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Seeking Alpha • Mar 31
Aspen Aerogels: Tariffs, Tesla And The Silver Lining
Summary Aspen Aerogels' growth is tied to the EV market, which faces uncertainty due to the potential elimination of the EV tax credit. Despite fears, Aspen Aerogels may benefit from Tesla's declining market share, as smaller EV players gain traction, particularly in Europe and China. US EV sales are expected to plateau until 2027, potentially limiting Aspen's revenue growth. But international markets offer expansion opportunities. The market may be overreacting to Aspen's stock decline. The company's prospects remain strong with increasing production capabilities in non-US markets. Read the full article on Seeking AlphaAnalyse-artikel • Feb 28
Positive Sentiment Still Eludes Aspen Aerogels, Inc. (NYSE:ASPN) Following 34% Share Price Slump
To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 34% in the...Seeking Alpha • Feb 14
Aspen Aerogels: Insulation Play Leaves Investors In The Cold
Summary Aspen Aerogels has seen significant revenue growth from EV insulation but faces challenges with EV demand, tariffs, and potential oversupply. Despite impressive revenue increases, shares have fallen due to concerns over market demand and halted construction of a new plant. The company reported strong 2024 sales and profits but faces a slowdown in EV revenue growth, with 2025 becoming a much tougher year. Given the uncertain outlook and recent setbacks, I remain cautious about ASPN stock but see the potential appeal if incremental improvements materialize throughout 2024. Read the full article on Seeking AlphaAnalyse-artikel • Feb 14
Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Seeking Alpha • Dec 23
Aspen Aerogels: There Are Reasons To Be Careful But It's So Cheap
Summary The company has recently taken on significant debt to finance its Statesboro plant. Stock were issued to improve the balance. The market didn't like but could make sense if it's compensated with growth thanks to the new Statesboro Plant. Q3 2024 earnings showed 92.93% YoY revenue growth and improved margins, but flat quarter-over-quarter sales led to a 28% stock decline. It's currently trading at 12 times forward EV/EBITDA and only 2.5 EV/Sales despite its revenue growth of almost 90%, so I think it's cheap. Read the full article on Seeking AlphaSeeking Alpha • Dec 02
Aspen Aerogels: Thermal Barriers Could Sustain Further Growth Despite A Chilly Market
Summary I find Aspen's 93% YoY revenue growth in Q3 2024 quite impressive, driven entirely by organic demand for PyroThin thermal barriers, with revenue guidance raised significantly this year. Gross margins climbed to 42% in the past quarter, while adj. EBITDA is projected to reach $90M in FY2024. Management's debt refinancing decision reduces dilution risks in the long term, a move I highly favor, despite the recent public offering. I foresee strong long-term growth from the Statesboro facility, set to generate $1.2–$1.6B annually, once completed in 2026. While potential changes to EV tax credits in the US and customer concentration pose risks, I believe Aspen's strong fundamentals and long-term growth drivers justify my cautious buy rating. Read the full article on Seeking AlphaSeeking Alpha • Nov 17
Aspen Aerogels: Despite Recent Pressure, This Is Intriguing
Summary Aspen Aerogels has transformed from an industrial insulation supplier to a key EV sector player, showing significant revenue growth and operating leverage. Despite impressive results and DOE funding news, shares fell due to a low-priced equity issue, concerns over EV demand, and uncertainty about a new factory. Shares dropped nearly 50% in a month, with third quarter sales up 93% YoY, driven by thermal barrier revenues, while facing capacity constraints. The company's valuation appears modest, with potential upside from the new factory and DOE loan, despite political and inflationary risks. Read the full article on Seeking AlphaAnalyse-artikel • Nov 07
With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For
Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a horrible month, losing 32% after a relatively good period...Seeking Alpha • Oct 28
Aspen Aerogels: Interesting Times
Summary Aspen Aerogels has transformed from an insulation supplier to a key player in the EV sector, showing strong revenue growth and operating leverage. Despite impressive quarterly results and preliminary DOE funding for a new plant, concerns about EV demand remain. The company raised $85 million through a share issuance, despite holding over $100 million in cash, raising questions about future funding needs. At around $20 per share, I see potential in Aspen Aerogels, despite recent share dilution and lack of sequential growth in Q3. Read the full article on Seeking AlphaAnalyse-artikel • Oct 17
Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 421 | N/A | 96 | N/A | 1 |
| 12/31/2027 | 284 | -15 | 14 | 7 | 5 |
| 12/31/2026 | 218 | -62 | 8 | 19 | 5 |
| 6/30/2026 | 202 | -126 | 34 | 49 | N/A |
| 3/31/2026 | 230 | -112 | 36 | 61 | N/A |
| 12/31/2025 | 271 | -390 | -5 | 33 | N/A |
| 9/30/2025 | 353 | -305 | 3 | 52 | N/A |
| 6/30/2025 | 397 | -312 | -3 | 58 | N/A |
| 3/31/2025 | 437 | -286 | -4 | 69 | N/A |
| 12/31/2024 | 453 | 13 | -41 | 46 | N/A |
| 9/30/2024 | 414 | 1 | -92 | 7 | N/A |
| 6/30/2024 | 357 | 1 | -132 | -21 | N/A |
| 3/31/2024 | 288 | -31 | -188 | -36 | N/A |
| 12/31/2023 | 239 | -46 | -218 | -43 | N/A |
| 9/30/2023 | 214 | -55 | -270 | -64 | N/A |
| 6/30/2023 | 190 | -71 | -335 | -94 | N/A |
| 3/31/2023 | 188 | -80 | -309 | -96 | N/A |
| 12/31/2022 | 180 | -83 | -272 | -94 | N/A |
| 9/30/2022 | 152 | -89 | -209 | -82 | N/A |
| 6/30/2022 | 146 | -68 | -113 | -51 | N/A |
| 3/31/2022 | 132 | -50 | -66 | -40 | N/A |
| 12/31/2021 | 122 | -37 | -32 | -19 | N/A |
| 9/30/2021 | 113 | -27 | -19 | -12 | N/A |
| 6/30/2021 | 107 | -26 | -13 | -7 | N/A |
| 3/31/2021 | 100 | -25 | -14 | -10 | N/A |
| 12/31/2020 | 100 | -22 | -13 | -10 | N/A |
| 9/30/2020 | 124 | -17 | -3 | 0 | N/A |
| 6/30/2020 | 135 | -12 | -5 | -2 | N/A |
| 3/31/2020 | 140 | -12 | N/A | 1 | N/A |
| 12/31/2019 | 139 | -15 | N/A | -1 | N/A |
| 9/30/2019 | 129 | -28 | N/A | -6 | N/A |
| 6/30/2019 | 117 | -32 | N/A | -4 | N/A |
| 3/31/2019 | 109 | -34 | N/A | -9 | N/A |
| 12/31/2018 | 104 | -34 | N/A | -9 | N/A |
| 9/30/2018 | 105 | -22 | N/A | -8 | N/A |
| 6/30/2018 | 108 | -19 | N/A | -5 | N/A |
| 3/31/2018 | 112 | -17 | N/A | -3 | N/A |
| 12/31/2017 | 112 | -19 | N/A | -5 | N/A |
| 9/30/2017 | 103 | -23 | N/A | -4 | N/A |
| 6/30/2017 | 105 | -23 | N/A | -1 | N/A |
| 3/31/2017 | 108 | -19 | N/A | -5 | N/A |
| 12/31/2016 | 118 | -12 | N/A | -1 | N/A |
| 9/30/2016 | 127 | -5 | N/A | 4 | N/A |
| 6/30/2016 | 129 | -4 | N/A | 1 | N/A |
| 3/31/2016 | 132 | -5 | N/A | 9 | N/A |
| 12/31/2015 | 123 | -6 | N/A | 5 | N/A |
| 9/30/2015 | 113 | -11 | N/A | 5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat ASPN de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat ASPN de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat ASPN de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van ASPN ( 25.6% per jaar) zal naar verwachting sneller groeien dan de markt US ( 13.5% per jaar).
Hoge groei-inkomsten: De omzet van ASPN ( 25.6% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ASPN naar verwachting over 3 jaar hoog zal zijn
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/18 15:49 |
| Aandelenkoers aan het einde van de dag | 2026/09/18 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Aspen Aerogels, Inc. wordt gevolgd door 15 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Benjamin Kallo | Baird |
| J. David Anderson | Barclays |
| Ryan Pfingst | B. Riley Securities, Inc. |